Gold prices steady near $3,400/oz as Sept rate cut bets rise; econ. data awaited
Yovan Arturo Sanchez, a director at Earth Science Tech, Inc. (OTC:ETST), recently acquired 100,000 shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The purchase, made on March 14, 2025, was executed on the open market at a price of $0.12 per share, amounting to a total investment of $12,000. The purchase comes as the company demonstrates strong financial performance, with revenue growth of 409% in the last twelve months and an impressive return on assets of 52%. According to InvestingPro analysis, the stock appears undervalued at current levels.
Following this transaction, Sanchez’s direct ownership in Earth Science Tech increased to 1,606,151 shares. This insider purchase aligns with broader management confidence in the company, which is one of several positive indicators identified by InvestingPro, including 10+ additional investment insights available to subscribers. The acquisition reflects Sanchez’s continued investment in the company, which operates in the pharmaceutical preparations industry and maintains a healthy gross profit margin of 72%.
In other recent news, Earth Science Tech, Inc. has amended the terms of its acquisition agreement with Las Villas Healthcare, LLC and Doconsultations.com, LLC. According to a recent 8-K filing with the U.S. Securities and Exchange Commission, the total purchase price has been reduced from $400,000 to $200,000. The initial agreement, dated January 30, 2025, included a $50,000 payment already made to the targets. Following this amendment, Earth Science Tech will pay the remaining $150,000 at the closing of the transaction. This closing is expected after the completion of a ninety-day due diligence period that is currently underway. The reduction in the purchase price marks a significant change in the acquisition’s terms. The strategic move to acquire these entities is part of Earth Science Tech’s broader efforts to expand its operations within the healthcare sector. These details were disclosed to inform shareholders and potential investors of the changes in the financial terms of the acquisition.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.